- Home
- FLEX vs PODD Comparison
FLEX vs PODD Comparison
Compare FLEX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLEX
- PODD
- Stock Information
- Founded
- FLEX 1990
- PODD 2000
- Country
- FLEX United States
- PODD United States
- Employees
- FLEX N/A
- PODD N/A
- Industry
- FLEX Electrical Products
- PODD Medical/Dental Instruments
- Sector
- FLEX Technology
- PODD Health Care
- Exchange
- FLEX Nasdaq
- PODD Nasdaq
- Market Cap
- FLEX 21.7B
- PODD 23.8B
- IPO Year
- FLEX 1994
- PODD 2007
- Fundamental
- Price
- FLEX $57.05
- PODD $313.99
- Analyst Decision
- FLEX Strong Buy
- PODD Strong Buy
- Analyst Count
- FLEX 9
- PODD 18
- Target Price
- FLEX $52.00
- PODD $337.06
- AVG Volume (30 Days)
- FLEX 3.6M
- PODD 666.3K
- Earning Date
- FLEX 10-29-2025
- PODD 11-06-2025
- Dividend Yield
- FLEX N/A
- PODD N/A
- EPS Growth
- FLEX 2.29
- PODD N/A
- EPS
- FLEX 2.28
- PODD 3.32
- Revenue
- FLEX $26,074,000,000.00
- PODD $2,359,500,000.00
- Revenue This Year
- FLEX $5.47
- PODD $29.13
- Revenue Next Year
- FLEX $4.15
- PODD $18.13
- P/E Ratio
- FLEX $25.02
- PODD $94.28
- Revenue Growth
- FLEX 0.92
- PODD 26.00
- 52 Week Low
- FLEX $25.11
- PODD $225.37
- 52 Week High
- FLEX $59.76
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- FLEX 53.08
- PODD 42.28
- Support Level
- FLEX $55.85
- PODD $306.03
- Resistance Level
- FLEX $59.30
- PODD $316.59
- Average True Range (ATR)
- FLEX 1.53
- PODD 9.61
- MACD
- FLEX -0.33
- PODD -2.26
- Stochastic Oscillator
- FLEX 47.91
- PODD 52.65
About FLEX Flex Ltd.
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.